Please log in to take part in the discussion (add own reviews or comments).
Cite this publication
More citation styles
- please select -
%0 Journal Article
%1 baldimmunecell
%A Bald, T
%A Landsberg, J
%A Lopez-Ramos, D
%A Renn, M
%A Glodde, N
%A Jansen, P
%A Gaffal, E
%A Steitz, J
%A Tolba, R
%A Kalinke, U
%A Limmer, A
%A Jonsson, G
%A Holzel, M
%A Tuting, T
%D 2014
%E Discov, Cancer
%J Cancer Discov
%K kalinke
%N 6
%P 674-687
%T Immune-cell poor melanomas benefit from PD-1 blockade after targeted type I IFN activation
%V 4
@article{baldimmunecell,
added-at = {2014-03-11T11:11:10.000+0100},
author = {Bald, T and Landsberg, J and Lopez-Ramos, D and Renn, M and Glodde, N and Jansen, P and Gaffal, E and Steitz, J and Tolba, R and Kalinke, U and Limmer, A and Jonsson, G and Holzel, M and Tuting, T},
biburl = {https://www.bibsonomy.org/bibtex/21842bc5290d3e6417e7b14bbdae6c14b/kalinke},
editor = {Discov, Cancer},
interhash = {7e28385eaaae65a508c6e8bbbfcbdaff},
intrahash = {1842bc5290d3e6417e7b14bbdae6c14b},
journal = {Cancer Discov},
keywords = {kalinke},
number = 6,
pages = {674-687},
pubmedurl = {http://www.ncbi.nlm.nih.gov/pubmed/24589924},
timestamp = {2014-06-24T09:27:43.000+0200},
title = {Immune-cell poor melanomas benefit from PD-1 blockade after targeted type I IFN activation},
volume = 4,
year = 2014
}